Max Financial Services Limited
What stands out?
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Nothing crossed the threshold for this company yet — see the data-coverage note below.
Who is this company?
Classified by the exchange under Financial Services › Financial Services › Insurance › Life Insurance.
- Market cap
- ₹49,191 cr
- FY2026 net premium
- ₹47,696 cr
- FY2026 net profit
- —
- Net worth
- —
- Total assets
- ₹1,98,936 cr
- EPS (basic)
- —
- Listed
- NSE · BSE
- Reporting
- IRDAIApr–Mar
Peer set used on this page: 4 life insurance.
Is the business growing?
Net premium grew 17.4% a year over 6 years, from ₹18,242 cr in FY2020 to ₹47,696 cr in FY2026.
Net premium and profit over the loaded history are shown above.
- Net premium growth per year
- +17.4%over 6 years (FY20–FY26)
- Net premium growth
- —vs last year
- Net profit growth
- —vs last year
- Change in net profit since FY20
- —
What changed recently?
In Q2 FY27 (Jul–Sep 2026), net profit ₹100 cr.
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 net profit was ₹100 cr, up 1608.7% from ₹6 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 EBIT was ₹139 cr, up 407.1% from ₹27 cr a year earlier.
Rule QTR_OPERATING_PERFORMANCE_CHANGE_YOY
Q2 FY27 interest (finance cost) was ₹30 cr, up 43.4% from ₹21 cr a year earlier.
Rule QTR_INTEREST_EXPENSE_CHANGE_YOY
A. Quarterly results
| Quarter | Net premium | YoY | Net profit | YoY |
|---|---|---|---|---|
| Q3 FY25 | — | — | 70 | −59.2% |
| Q4 FY25 | — | — | 38 | −176.4% |
| Q1 FY26 | — | — | 86 | −44.6% |
| Q2 FY26 | — | — | 6 | −95.8% |
| Q3 FY26 | — | — | 45 | −35.9% |
| Q4 FY26 | — | — | −32 | −182.3% |
| Q1 FY27 | — | — | 118 | +36.8% |
| Q2 FY27 | — | — | 100 | +1608.7% |
B. TTM snapshot
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
- Net premium
- —TTM
- PBT
- ₹259 crTTM
- Net profit
- ₹232 crTTM
C. Corporate actions
Is it becoming more profitable?
Profitability ratios aren't calculated for this company's filing format yet.
The metrics this section charts aren't mapped for this company's sector yet — see the data-coverage note in section 10.
- Net margin
- —
- Expense ratio
- —
- Benefits / premium
- —
- ROE FY2026
- —
Is financial health improving?
Balance-sheet figures aren't calculated for this company's filing format yet.
The metrics this section charts aren't mapped for this company's sector yet — see the data-coverage note in section 10.
- Net worth
- —
- Total assets
- ₹1,98,936 cr
- Investments
- ₹9,716 cr
- Policyholders' surplus
- —
How does it compare with peers?
Its peer group is too small for a meaningful ranking. Its P/E of 212.2 compares with a peer median of 65.4.
Ranked against 4 life insurance (FY2026, consolidated). No peer-relative rule fired for this company.
Revenue growth
MFSL · set median 11.3%
Return on equity
MFSL · set median 13.7%
P/E ratio
MFSL · 4th of 4 · set median 65.4×
- P / E
- 212.2×TTM to Sept 26
- P / B
- —latest book
- P / S
- 1.0×TTM sales
- Earnings yield
- 0.5%TTM to Sept 26
On the trailing twelve months. Last full year: · P/S 1.0×.
How has the stock performed?
The share price is down 15.3% over 1 year, up 46.3% over 3 years (13.5% a year) and up 50.8% over 5 years (8.6% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 23.4% below its 52-week high.
Long-term price performance is shown above.
- 1-year return
- −15.3%
- 3-year return
- +46.3%
- 5-year return
- +50.8%
- From 52-wk high
- −23.4%
What does the technical data say?
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
- vs 50-day avg
- Above₹1,359
- vs 200-day avg
- Below₹1,560
- RSI (14)
- 63.6neutral
- MACD histogram
- 25.2
- From 52-wk high
- −23.4%
- From 52-wk low
- +21.9%
- 30-day volatility
- 34.0%ann.
- 6-month return
- −11.8%
What should I investigate further?
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
Nothing is flagged for review for this company.
- Insurer-specific metrics (APE, VNB, embedded value, solvency ratio) are not yet mapped — profitability insights are unavailable.
The numbers
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total income | 18,242 | 31,288 | 31,188 | 31,431 | 46,618 | 46,497 | 47,696 |
| Investments | 3,372 | 4,063 | 6,021 | 5,431 | 5,881 | 9,135 | 9,716 |
| Operating cash flow | — | 8,621 | 8,496 | 9,922 | 6,107 | 8,352 | 11,473 |
| Ratio | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Net premium growth YoY | — | — | — | — | — | — | — |
| Profit growth YoY | — | — | — | — | — | — | — |
| Profitability & efficiency | |||||||
| Net margin % | — | — | — | — | — | — | — |
| Expense ratio % | — | — | — | — | — | — | — |
| Benefits / premium % | — | — | — | — | — | — | — |
| Return on equity % | — | — | — | — | — | — | — |